CI
IBD icon

CX Institutional’s Inspire Corporate Bond ETF IBD Stock Holding History

CX Institutional’s Portfolio IBD Stock Details IBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-365
Closed -$9K – 1604
2025
Q4 		$9K Buy
+365
New +$8.83K ﹤0.01% 1208

Other funds holding IBD

IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
FA
Faithward Advisors Lancaster, Pennsylvania $701M AUM 32.17% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $378M AUM 15.71% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
PFG
PAX Financial Group San Antonio, Texas $586M AUM 15.84% 1-Year Est. Return
PAW
Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

CX Institutional's IBD Position: Q1 2026 in Review

CX Institutional sold out of Inspire Corporate Bond ETF (IBD) in Q1 2026, closing a stake of 365 shares — an estimated $9K sold.

CX Institutional first reported a position in IBD in Q4 2025 and held it in 1 quarter. The position peaked at $9K in Q4 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • CX Institutional reported no remaining Inspire Corporate Bond ETF position as of Q1 2026 after selling out during the quarter.
  • CX Institutional sold 365 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $9K.
  • CX Institutional first reported a position in Inspire Corporate Bond ETF in Q4 2025 and held it in 1 quarter.
  • CX Institutional's Inspire Corporate Bond ETF position peaked at $9K in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on CX Institutional's 13F filing for Q1 2026, filed 6 Apr 2026.